Objective-Dyslipidemia is a component of the metabolic syndrome, an established risk factor for atherosclerotic cardiovascular disease, and is also observed in various autoimmune and chronic inflammatory conditions. However, there are limited opportunities to study the impact of acquired dyslipidemia on cardiovascular and immune pathology. Approach and Results-We designed a model system that allows for the conversion to a state of acute hyperlipidemia in adult life, so that the consequences of such a transition could be observed, through conditionally deleting APOE (apolipoprotein E) in the adult mouse. The transition to hypercholesterolemia was accompanied by adaptive immune responses, including the expansion of T lymphocyte helper cell 1, T follicular helper cell, and T regulatory subsets and the formation of germinal centers. Unlike steady-state Apoe −/− mice, abrupt loss of APOE induced rapid production of antibodies recognizing rheumatoid disease autoantigens. Genetic ablation of the germinal center reduced both autoimmunity and atherosclerosis, indicating that the immune response that follows loss of APOE is independent of atherosclerosis but nevertheless promotes plaque development. Conclusions-Our findings suggest that immune activation in response to hyperlipidemia could contribute to a wide range of inflammatory autoimmune diseases, including atherosclerosis. Visual Overview-An online visual overview is available for this article. Genetic mouse models that have provided important insights into the pathogenesis of atherosclerosis are based on gene targeting in the germline, leading to congenital defects in lipoprotein metabolism. One of the most widely used mouse models is the apolipoprotein E-deficient (Apoe −/− ) mouse, in which targeted deletion of the Apoe gene 8,9 leads to severe hyperlipidemia and spontaneous atherosclerosis together with inflammation. The Apoe −/− model shows several similarities to the human metabolic syndrome, including chronic inflammation and insulin resistance. 10 However, it is difficult to dissect the relationship between hyperlipidemia, inflammation, and atherosclerosis because of the congenital nature of disease in this model.
H yperlipidemia is a major risk factor for atherosclerotic cardiovascular disease. Accumulation of LDL (low-density lipoprotein) particles in the arterial intima elicits both innate and adaptive immune responses, the outcome of which is a chronic inflammatory process with build-up of atherosclerotic plaques. 1, 2 Retention and modification of LDL in the arterial wall lead to scavenging by macrophages, resulting in foam cell production, cholesterol microcrystal formation, and production of interleukin-1β. 3 LDL itself is also a major antigenic factor driving an adaptive immune response. 4, 5 Components of LDL are presented as autoantigens to T-cells, which can contribute to macrophage activation and also instigate a B-cell response leading to the production of antibodies to modified LDL epitopes. 6 A recently published clinical trial shows that blockade of inflammatory signal by intravenous administration of an antiinterleukin-1b antibody significantly reduces clinical events in patients with atherosclerosis. 7 Studies of monogenic disorders of lipid metabolism, such as familial hypercholesterolemia, have yielded important information about its mechanisms and regulation. Most cases of cardiovascular disease in humans are, however, not because of monogenic disorders but complex conditions that involve exogenous factors, including nutrition and infections as well as genetically controlled, intrinsic ones. In recent years, it has become evident that the metabolic syndrome characterized by hyperlipidemia, hypertension, abdominal obesity, and insulin resistance is an important contributor to cardiovascular morbidity. It is an acquired condition with signs of chronic inflammation and with a hyperlipidemic profile that involves elevated VLDL (very-lowdensity lipoprotein) as well as LDL particles. Unfortunately, our understanding of the relationship between acquired conditions such as metabolic syndrome, chronic inflammation, and atherosclerosis is limited, in part because of limited opportunities to study these conditions by experimental approaches.
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Genetic mouse models that have provided important insights into the pathogenesis of atherosclerosis are based on gene targeting in the germline, leading to congenital defects in lipoprotein metabolism. One of the most widely used mouse models is the apolipoprotein E-deficient (Apoe −/− ) mouse, in which targeted deletion of the Apoe gene 8, 9 leads to severe hyperlipidemia and spontaneous atherosclerosis together with inflammation. The Apoe −/− model shows several similarities to the human metabolic syndrome, including chronic inflammation and insulin resistance. 10 However, it is difficult to dissect the relationship between hyperlipidemia, inflammation, and atherosclerosis because of the congenital nature of disease in this model.
The other commonly used mouse model is based on targeting of the LDL receptor. Because of differences in lipid metabolism between rodents and man, the Ldlr −/− mouse is dyslipidemic but not hypercholesterolemic at birth. Instead, cholesterol rises on feeding of a high-fat, Western diet, making it possible to induce the disease process postnatally. For obvious reasons, the metabolic profile of the Ldlr −/− mouse is more similar to familial hypercholesterolemia than it resembles the metabolic syndrome. Furthermore, the change of diet introduces a possible confounding factor in the experiment. Thus, it is not currently possible to separate the immune response to hyperlipidemia vis à vis the inflammatory response to atherosclerotic lesion formation by using currently available genetic mouse models.
Dyslipidemia is also associated with several other autoimmune conditions, particularly rheumatoid arthritis, systemic lupus erythematosus, 11 and Sjögrens disease. It is well-established that a preexisting rheumatological autoimmune disorder increases the probability of developing cardiovascular disease. One possibility is that dyslipidemia could be a common initiating and contributing factor for both atherosclerosis development and these more orthodox autoimmune conditions. There is mounting evidence that cholesterol loading of hematopoietic cells can lead to immune abnormalities. 12 Dendritic cell-specific loss of the ATP-binding cassette transporters A1 and G1 results in systemic lupus erythematosus-like symptoms, 13 as does maintaining Apoe −/− mice on a Western diet.
14 Alternatively, a recent report suggested loss of Apoe must be combined with loss of liver X receptor β to induce autoimmunity and kidney pathology. 15 Nevertheless, the consequences of these dysregulated immune responses on atherosclerosis development remain unknown. Is this autoimmunity actually a defense response that helps prevent atherosclerotic plaque formation, or is the autoimmune response to dyslipidemia a broad contributor to multiple disease states?
We reasoned that if the Apoe gene were deleted in the adult mouse, this would lead to rapid hypercholesterolemia and potentially reveal any inflammatory responses that accompany this disruption in homeostasis. On conditional deletion of the Apoe gene in the adult mouse, we observed a rapid T-and B-cell response culminating in the formation of germinal centers (GCs) and systemic autoimmunity. Genetic loss of either mature B-cells or GC responses revealed that this autoimmune response promotes atherosclerotic lesion development. Our findings demonstrate that dyslipidemia initiates broad adaptive immune responses that could have consequences for multiple chronic autoimmune diseases.
Materials and Methods
The data that support the findings of this study are available from the corresponding author on reasonable request.
Mice
Mice containing a floxed allele of Apoe have been described previously 16 and backcrossed to the C57/Bl6 strain at 10×. The ROSA26CreERt2 strain 17 was imported from Jackson lab and backcrossed to the C57/Bl6 strain 9×. Aicda-Cre, and Pax5 +/− Apoe −/− Cd23-Cre mouse lines were bred and maintained independently and intercrossed together to generate experimental and control littermates and backcrossed to the C57/Bl6 strain at least 6×. Mice were maintained under specific pathogen-free conditions. Breeding mice were fed standard low-fat diet R36 (1260 kJ/100 g, 18% protein, 4% fat; Lantmännen, Sweden), and adult experimental mice received chow diet R70 (1254 kJ/100 g, 14% protein, 4.5% fat; Lantmännen, Sweden). Western diet consisted of R638 (15.6 MJ/kg, 17.2% protein, 21% fat; Lantmännen, Sweden). All animal experiments were performed according to valid ethical permits and regularly controlled by the Swedish Veterinary authorities and the Stockholm Board for Animal Ethics.
Tamoxifen Induction
A 60 mg/mL solution of tamoxifen was prepared by dissolving first in ethanol and then peanut oil and heating to 50°C until the tamoxifen is dissolved so that the final solution contained 10% ethanol and 90% peanut oil by volume. Approximately 150 μL of this solution (9 mg total tamoxifen) was administered as a single dose by oral gavage using a bulb-tipped feeding needle into mice aged 10 to 12 weeks of both genders, unless otherwise stated. Mice were routinely bled several days after tamoxifen induction to monitor plasma cholesterol levels. Occasional experimental mice that did not show the expected increase in plasma cholesterol were excluded from the analysis.
Splenectomy
Mice were anaesthetized with isofluorane, and a 1-cm incision was made on the left side of the abdomen. The spleen was extracted from the peritoneal cavity, and vessels and nerves slowly cauterized with a burner. The peritoneum and skin were finally sewed with reabsorbing vicryl sutures. Sham-operated mice were opened and resutured thereafter. After ≈2 weeks of recovery, mice received tamoxifen as described above and were fed Western diet.
Bone Marrow Transplantation
Donor mice were euthanized with carbon dioxide, and the tibia and femur from both hind legs were removed. Bones were crushed using a pestle and mortar. The cell suspension was then filtered through a 100-μm nylon mesh, and the erythrocytes were lysed on ice using inhouse made ammonium-chloride-potassium buffer. Cells were then counted, washed in Hanks' balanced salt solution (1×), and the pellet was resuspended to the final concentration of 4 
Cholesterol and Lipid Profiling
The levels of cholesterol and triglycerides in mouse plasma were quantified using an enzymatic colorimetric method (Randox Laboratories) following the manufacturer's protocol. Cholesterol lipoprotein profiles in plasma were determined by size-exclusion chromatography using HR10/30 Superose 6 column (GE Healthcare) and a Discovery BIO GFC-500 precolumn (5 cm×7.8 id; Supelco; Sigma-Aldrich) coupled to Prominence UFLC system (Shimadzu). The system was equilibrated with Tris-buffered saline, pH 7.4, and fractions were collected using Foxy Jr. fraction collector (Teledyne Isco, Inc). Total cholesterol in each fraction was determined as described above.
Atherosclerosis Analysis
Mice of a defined sex were analyzed, 23 as indicated in the figure legends. Aortas for en face staining were rinsed in 70% ethanol for 5 minutes and stained in Sudan IV (5 g Sudan IV Sigma, 500 mL 70% ethanol, 500 mL 100% acetone) for 7 to 8 minutes. After a washing step in 80% ethanol for 30 seconds, aortas were rinsed in PBS and photographed using a light microscope. Lesion quantification was performed with ImageJ software. Oil Red O working solution was prepared from a stock solution (1 g oil red O, O0625 Sigma, in 100 mL isopropanol) by diluting 150 mL of stock in 100 mL H 2 
Flow Cytometry
Spleen, lymph nodes, bone marrow, aorta, and peritoneal cavity lavage were fractioned to single-cell suspension and filtered with 100 µm sterile cell strainers. Erythrocytes, when present, were lysed for 3 minutes with 1 mL of ammonium-chloride-potassium buffer on ice. Cells were seeded at 100×10 6 cells/mL, and Fc blocking was performed for 30 minutes. Staining was performed on ice for 40 minutes against mouse CD3ε (PB 500A2 or PerCPs 145-2C11), CD4 (APCH7 GK1. 
, and HPC2 (Lin-Sca1+c-Kit+ CD150+ CD48+). Samples were acquired with a Dako CyAn (Beckman Coulter) flow cytometer and analyzed with FlowJo software.
Immunofluorescence
Spleen sections (10 μm in thickness) were fixed in ice-cold acetone and blocked with Fc-Block (CD16/CD32) in PBS 0.1% BSA before incubation with Alexa Fluor 488-conjugated antibody to mouse GL7 (GL7, Biolegend), allophycocyanin-conjugated IgD (11-26c.2a, eBioscience), and counterstained with DAPI (4',6-diamidino-2-phenylindole; Sigma D8417). For detection of immune complex deposition in the kidneys, kidneys were mounted in optimal cutting temperature compound, and 6 µm thick frozen sections were blocked with normal horse serum (Vector S-2000) then stained against IgM and IgG2c while nuclei were DAPI stained.
Aortic arches were harvested, removed surrounding fat and adventitia, and fixed in 4% paraformaldehyde. After they were cut open longitudinally, the arch containing lesser and greater curvature was pinned on a parafilm bed. Spleen sections (10 µm in thickness) were fixed in 4% paraformaldehyde. Permeabilization was performed with 0.2% Triton X-100 in PBS. Blocking was performed with normal horse serum followed by primary antibody (CD11c N418, biotin, Pharmingen) and secondary antibody (Streptavidin Dylight 488 conjugated [Vector SA-5488]) staining. Subsequently, tissue was stained with Nile red (Sigma N3013)and finally DAPI. Confocal images were taken using a Leica TCS inverted microscope.
In Vitro Stimulation of T-Cells
Cell culture was performed in Iscove's modified Dulbecco's medium supplemented with penicillin/streptomycin, glutamine, 2-mercaptoethanol (all from Invitrogen), and 8% heat-inactivated FCS (Sigma). To analyze cytokine production, phorbol 12-myristate 13-acetate (50 ng/mL) and 5 μmol/L ionomycin (both from Sigma) were added to cultures of total splenocytes (4×10 6 /mL) for 3 hours in the presence of Brefeldin A (5 μmol/L; Sigma). The eBioscience Fixation/ Permeabilization Kit was used for intracellular staining of cells for cytokines using the antibodies interferon-γ (XMG1.2), interleukin-10 (JES5-16E3), and interleukin-4 (11B11).
Cell Isolation From Aorta
Mice were euthanized using carbon dioxide, and the vasculature was perfused by left ventricular puncture using PBS. All abdominal organs were removed leaving aorta with adventitia and heart intact.
Spleens were collected as digestion controls. Periaortic adipose tissue and para-aortic lymph nodes were carefully removed under a dissection microscope. Whole aortas were then microdissected and weighed. Spleens were cut in pieces with the same weight as the aortas for digestion control. Tissues were then incubated for 60 minutes in 37°C in an enzymatic solution (1 mL/10 mg tissue) of PBS and 20 mmol/L HEPES with 488 U/mL collagenase I, 230 U/mL collagenase XI, 125 U/mL hyaluronidase, and 60 U/mL DNase I. After digestion, tissues were mashed through 70-μm cell strainers and analyzed by fluorescence-activated cell sorter.
ELISA
ELISA for total immunoglobulin isotypes in mouse plasma were performed by coating plates with isotype-specific antibodies for capture. Detection was performed using alkaline phosphatase-coupled goat anti-mouse Ig isotype (Southern Biotechnology Associates) and alkaline phosphatase yellow (pNPP) Liquid Substrate (Sigma-Aldrich). For autoantigens, ELISA plates were coated with PC-BSA (Biosearch Technologies), cardiolipin (Sigma-Aldrich), lipopolysaccharide (Invivogen), and recombinant insulin (Sigma-Aldrich). Serum was added after blocking, and antigen-reactive IgG was measured with alkaline phosphatase-conjugated anti-mouse IgG antibody (SouthernBiotech). Antibodies against Ro-52, Ro-60, SmD1, and SS-B were measured using commercial kits (Signosis, Inc) following manufacturer's instructions. All samples were corrected for background binding.
Copper oxidized LDL and malondialdehyde-modified LDL were prepared as described previously. 25 Alkaline phosphataselabeled goat anti-mouse IgM (μ-chain specific; Sigma-Aldrich) and goat anti-mouse IgG (γ-chain specific; Sigma-Aldrich) were used for detection. T15-clonospecific antibodies (eg, E06) in plasma were quantified using a chemiluminescent-based capture assay. In brief, the monoclonal anti-idiotypic antibody AB1-2, a mouse IgG1 which identifies a determinant requiring coexpression of the canonical T15 VH/T15 VL regions, 26 was used as capture antibody. T15-clonospecific antibodies were detected using an alkaline phosphatase-labeled goat anti-mouse IgM (μ-chain specific; SigmaAldrich). Purified E06, a clonospecific IgM monoclonal antibody, 27 was used as a positive control. ApoE protein levels in mouse plasma were measured with a Mabtech ELISA kit (product code 3752-1HP-2) according to manufacturer's instructions.
Statistics
Quantitative data are presented as mean±SEM. Outliers were identified using ROUT analysis. Normal distribution was examined using either the D'Agostino-Pearson or Kolmogorov-Smirnov test. Differences between 2 groups were tested by Student t test for unpaired means or Mann-Whitney test if normal distribution was not confirmed. One-way or 2-way of ANOVA was used for analysis of >2 groups followed by Bonferroni multiple comparison test or uncorrected Fisher least significant difference. Statistical significance was assumed if P reached a value of 0.05 or lower. All data were analyzed in GraphPad Prism.
Results

Deletion of the Apoe Gene in the Adult Mouse Creates an Inducible Model of Hyperlipidemia and Atherosclerosis
We hypothesized that somatic deletion of the Apoe gene in the adult mouse would produce a similar phenotype as germline deletion of Apoe. 8, 9 This experimental approach is dependent on achieving a high deletion frequency of the Apoe allele as reintroduction of the APOE protein into Apoe −/− mice to only 4% of wild-type levels (achieved by bone marrow transplantation) fully rescues blood lipid profiles and prevents atherosclerosis. 28 We crossed a floxed allele of Figure 1A ; Figure IA in the online-only Data Supplement).
We next measured plasma cholesterol levels at various time points after the administration of tamoxifen. Four days post-deletion, we noticed a significant increase in cholesterol levels that continued upwards at later time points, reaching over 500 mg/dL 21 days post-induction, a similar cholesterol level to what we observe in the Apoe −/− strain 29 ( Figure 1B ). In addition, control mice showed enrichment of cholesterol in the HDL (high-density lipoprotein) fraction as expected, whereas experimental mice incorporated cholesterol into their chylomicron/VLDL fraction already 10 days post-tamoxifen, and this was further increased at day 20 ( Figure 1C ). Nonfasted plasma triglyceride levels were unaltered between control and experimental mice even 140 days after APOE deletion ( Figure 1D) .
Next, we investigated whether loss of APOE in the adult is sufficient to induce atherosclerosis similar to the conventional Apoe −/− strain. We examined mice 140 days after a single tamoxifen treatment, maintained on a chow diet throughout, and confirmed that plasma cholesterol remained elevated ( Figure 1E ), and APOE protein was largely absent at this time point ( Figure IB in the online-only Data Supplement). We isolated hearts and aortas from both control and experimental mice and quantified atherosclerotic lesions in Oil Red O-stained cryosections of the aortic root ( Figure 1F ) or en face within the aortic arch and thoracic aorta after Sudan IV staining ( Figure 1G ). As expected, control mice were negative for plaque formation. However, experimental mice maintained on a normal chow diet readily demonstrated atherosclerotic lesion formation that is characteristic of the Apoe −/− strain although the atherosclerotic burden was lower than the Apoe −/− strain ( Figure 1F ). In summary, by deleting the Apoe gene in the adult mouse, we created an inducible model of atherosclerosis and hyperlipidemia.
Hyperlipidemia Can Induce Inflammation Independently of Atherosclerosis Plaque Formation
We hypothesized that an acute increase in plasma lipid levels may activate the immune system in a manner that is not evident in the conventional Apoe −/− strain. When analyzing the spleen at day 10 after APOE deletion, we observed a marked increase in B-cells bearing the surface activation markers CD95 and GL7, indicating that GCs are formed at the onset of hyperlipidemia (Figure 2A) . Immunofluorescence of spleen sections at day 10 confirmed the presence of GCs ( Figure 2B ). These GCs could also be observed at day 21 ( Figure IC We next examined the T-cell populations as CD4+ T-cells have been shown to become activated in the context of atherosclerosis. 5 We were unable to detect a significant increase in the absolute numbers of CD4+ or CD8+ T-cells at any time point up to 140 days or a transition of CD4+ T-cells from a naïve (CD44 − CD62L + ) to an effector/memory state (CD44 + CD62L − ) 10 or 21 days after tamoxifen administration ( Figure IIIA and IIIB in the online-only Data Supplement), but limited activation was present at day 140 ( Figure IIIC in the online-only Data Supplement). Similarly, splenic myeloid populations were unaffected at day 10 ( Figure IVA in the online-only Data Supplement). We further examined the splenic CD4 + T-cell pool to determine whether specific effector lineages were induced. The data showed significant increases in T lymphocyte helper cell 1 (CD4 + Tbet + ) and Treg (T regulatory; CD4 + Foxp3 + ) populations in the spleen at day 10 ( Figure 2D ) when blood cholesterol levels have approximately tripled in experimental mice.
We next wished to determine whether this specific lymphoid activation present in the spleen at day 10, typified by GC formation, precedes definitive atherosclerosis formation. Unsurprisingly, visual inspection of the aorta 10 days after tamoxifen administration, corresponding to only 6 days of raised plasma cholesterol levels, did not reveal any fatty streak formation (data not shown). We further tested for intracellular neutral lipid deposition through Nile Red staining of the luminal face of the lesser curvature of the aorta as previously performed ( Figure IVB We next subjected the mice to a Western diet regime to determine whether immune activation in peripheral lymphoid organs beyond the spleen could be induced. Under these conditions we still observed GC formation at day 21 ( Figure VA in the online-only Data Supplement) and day 70 ( Figure 2E ) after tamoxifen addition while other B-cell subsets were not expanded. However, additional GC formation could also be observed in peripheral aortic and inguinal lymph nodes (Figure VB in the online-only Data Supplement). Hematopoietic stem cell populations and B-cell progenitors in the bone marrow were also expanded ( Figure VIA and VIB in the online-only Data Supplement). Analysis of the T-cell compartment at day 70 after tamoxifen administration in mice maintained on a Western diet revealed that T follicular helper cells, but not T-cells in general, were increased in frequency and number ( Figure 2F ). Intracellular cytokine staining after in vitro stimulation with phorbol 12-myristate 13-acetate and ionomycin revealed increases in interferon-γ, interleukin-4, and interleukin-10 positive cells in experimental mice compared with controls. Levels of interleukin-13 and interleukin-17 were not significantly increased ( Figure 2G ). Finally, we compared control and experimental mice with Apoe −/− and Ldlr −/− mice, with all strains placed on a Western diet for 2 weeks. As previously reported, 30 Apoe −/− mice displayed GC formation in the spleen but not the Ldlr −/− strain. T-cell subsets were broadly similar across all 4 strains, with an exception of lower CD8 + T-cell numbers in Apoe −/− mice compared with both control and experimental strains ( Figure  VII in the online-only Data Supplement).
Transition to Hyperlipidemia Induces Broad Humoral Responses Against Self-Antigens
We focused on investigating the immune responses of mice 70 days after the commencement of a Western diet and examined whether the observed immune activation was coupled to autoimmune B-cell activation. As a consequence of the GC formation, splenic plasma cell formation was increased in experimental versus control mice ( Figure 3A) . Experimental mice presented increases in the titres of plasma immunoglobulins IgM and IgG but not IgA. Among the IgG isotypes, IgG2b and IgG2c were significantly increased whereas IgG1 and IgG3 were not affected compared with control mice. Noticeably, we did not observe a similar pattern in Apoe −/− mice, which displayed elevated levels of IgA and IgG3 immunoglobulin isotypes, but had reduced IgG1 compared with both control and experimental mice ( Figure 3B) . Surprisingly, these increased titres did not result in increases antibody responses against modified LDL in control, experimental, or Apoe −/− mice maintained on a Western diet for 10 weeks ( Figure 3C ). However, broad increases in IgM and IgG reactivity against malondialdehyde-modified LDL, copper oxidized LDL, and antiphosphocholine responses were significantly increased in experimental mice versus controls after 5 weeks of Western diet ( Figure 3D ).
Further humoral differences were also observed when comparing the acute response to the chronic deletion of Apoe. Experimental mice showed IgG reactivity against common autoantigens both 5 and 10 weeks after tamoxifen administration relative to controls. This included several autoantigens involved in Sjögren syndrome and systemic lupus erythematosus, including Ro-52 and Ro-60, SmD1, cardiolipin, and SSB (Sjögren's syndrome type B) (La). Apoe −/− mice that were also maintained on a Western diet for 10 weeks did not present broad self-recognition ( Figure 4A and 4B ). There were also increases in IgM and IgG antibodies against atherosclerosis-associated antigens in chow-maintained mice over time ( Figure VIII in the online-only Data Supplement). Examination of kidney sections from experimental mice, but not controls, revealed widespread IgM and IgG deposition ( Figure 4C ). In summary, conditional loss of Apoe results in a distinct and autoimmune-biased humoral immune response compared with the homeostatic Apoe −/− strain.
Spleen Does Not Play an Essential Role in Promoting Inflammation in Response to Dyslipidemia
We next addressed the relevance of this splenic autoimmune response to atherosclerosis lesion development. The spleen has previously been shown to have a central function in regulating immune responses in atherosclerosis. We, therefore, performed a splenectomy or alternatively a sham operation on experimental mice maintained on a Western diet for 70 days to determine the role of this organ in the response to inducible hyperlipidemia. Loss of the spleen resulted in decreases in the B2 and B1a, but not the B1b cell population in the peritoneal cavity, similar to previously reported splenectomized mice ( Figure IXA in the online-only Data Supplement). We next assessed how serum immunoglobulin titres were affected and found significant decreases in total IgM and IgG but not IgA, with IgG2b the most significantly affected of the IgG isotypes ( Figure IXB in the onlineonly Data Supplement). However, plasma cholesterol levels were not altered ( Figure IXC in the online-only Data Supplement). Atherosclerotic lesion development in the aortic root was slightly but significantly increased on loss of the spleen, possibly because decreases in IgM levels can result in increased atherosclerosis ( Figure IXD in the online-only Data Supplement).
Systemic B-Cell Response Dictates the Inflammatory Proatherosclerotic Response to Hyperlipidemia
We next adopted a genetic approach to ablate B-cell lineages systemically in response to hyperlipidemia. We engineered 2 strains that conditionally delete the B-cell-specific transcription factor Pax5, which is required for B-cell identity and function. [31] [32] [33] We first used Cd23-Cre, which is expressed in transitional B-cells 21 and deletes in follicular and marginal zone B-cells, 34 as well as memory B-cells after immunization. 35 This strain was additionally crossed onto the Apoe −/− background so that they could be bone marrow transplanted into Figure 5A ). Total plasma cholesterol levels were unaffected ( Figure 5B ). However, in contrast to splenectomized mice, we observed broad decreases in immunoglobulin isotypes ( Figure 5C ) and also reductions in autoantibody production and IgG responses against malondialdehyde-modified LDL ( Figure 5D ). We next assessed atherosclerosis development and found a significant 44% decrease in aortic root lesion formation on loss of mature B-cell function and autoreactive antibody production ( Figure 5E ).
Deletion of the GC Response Results in Reduced Atherosclerosis
Because of the broad B-cell defects observed in Pax5 fl/− Cd23-Cre Apoe −/− transplanted hosts, we next attempted to effectively ablate only the GC response. Aicda-Cre specifically deletes in GC B-cells and has previously been utilized to abolish GC function. 21, 36 We, therefore, transplanted Pax5 fl/− Aicda-Cre Apoe −/− bone marrow into Apoe fl/− ROSA26 CreERt2/+ hosts. We observed normal B-cell numbers but selective loss of GCs and plasma cells relative to controls when analyzed 10 weeks after tamoxifen administration and maintained on a Western diet ( Figure 6A ). Similar to the Pax5 fl/− Cd23-Cre Apoe −/− transplanted hosts, there was no effect on plasma cholesterol levels ( Figure 6B ). However, as expected, the loss of GC function decreased antibody titres ( Figure 6C ), as well as autoantibody production and IgG responses against malondialdehyde-modified LDL ( Figure 6D ). T-cell subsets were unaffected ( Figure X in the online-only Data Supplement). Atherosclerosis was significantly decreased by 38%, directly linking the GC response to disease development ( Figure 6E ). Similar reductions were obtained using male recipients (data not shown). These finding show that the GC-dependent autoimmune response to hyperlipidemia promotes atherosclerosis development. 
Discussion
Germline deletion of the Apoe gene results in mice that are hyperlipidemic from birth, show signs of chronic inflammation, and develop spontaneous atherosclerosis. In this study, we have discovered that transition to an APOE null state in the adult mouse leads to a sequence of events, with hyperlipidemia rapidly followed by an adaptive immune response characterized by the formation of splenic GCs and linked to systemic autoimmunity. Immune activation preceded the development of atherosclerotic plaques, indicating that changes in metabolism in adult life can have direct effects on immunity, independent of but impacting on atherosclerosis.
Immune activation after loss of APOE expanded T lymphocyte helper cell 1, T follicular helper cell, Treg, and GC B-cell numbers. APOE has also been suggested to prevent proliferation of T-cells in a nonspecific manner. 37 However, we did not observe a general expansion of T-cells on somatic loss of Apoe in vivo in the time windows we examined. 
ROSA26
CreERt2/+ mice displaying broad reactivity against common autoantigens, whereas the germline-deleted Apoe −/− strain showed much lower reactivity to self-antigens. It is possible that this break in tolerance is because of the abrupt shift to dyslipidemia in the conditional deletable mouse, whereas the Apoe −/− strain that is born hypercholesterolemic has greater opportunities for immune education or longer time to anergize cells against self. Ldlr −/− mice did not develop GCs during the acute phase after a transition to hypercholesterolemia, in agreement with a recent study indicating that extended periods of a high-fat diet are necessary to induce T follicular helper cell and GC formation in the Ldlr −/− strain. 38 As this diet also induces atherosclerosis formation, it is not clear whether the appearance of GCs is related to the increase in plasma cholesterol or plaque formation. A strategy whereby acute hypercholesterolemia can be induced on loss of LDLR (low-density lipoprotein receptor) would be required to see if the immune activation observed on loss of APOE is a generalized response to hypercholesterolemia. Nevertheless, this strain of conditional loss of APOE will be useful for further studies, whereby an acute induction of hypercholesterolemia is desired.
The spleen forms an intimate relationship with the blood by responding to circulating pathogens and autoantigens and has a proven protective function against atherosclerosis in mice 39-42 and complications arising from atherosclerosis in humans. 43, 44 The spleen may also possess proatherosclerotic functions through the supply of monocytes. 45 Noticeably, IgG1 and IgG2c were robustly produced in the absence of the spleen implicating other secondary lymphoid organs in the humoral autoimmune response. However, serum IgM titres and peritoneal B1a cells were strongly decreased after splenectomy, which are both thought to help protect against atherosclerosis lesion formation. The balance of these plaque promoting and regressing activities may explain the almost neutral effect of spleen removal with regards to atherosclerosis. The discrepancy in immune responses between the germline and inducible Apoe −/− models emphasizes the importance of further studies investigating changes in lipid metabolism in adult life as risk factors for cardiovascular and other diseases. Our inducible Apoe −/− model should be helpful in such investigations. Ingestion of a lipid-rich meal in humans can result in acute postprandial inflammation, with short-term increases in blood myeloid and lymphoid populations. 46, 47 In mice however, the immune response to raised blood lipid levels is thought to be of a chronic low-grade nature with monocytosis developing over time. 48 This expansion in myeloid cells is thought to be a cell intrinsic function of APOE in hematopoietic progenitors. CreERt2/+ hosts of both sexes. Analysis was performed at day 70 after tamoxifen administration, and mice were maintained on a Western diet. Absolute cell numbers for the indicated B-cell subsets are indicated. B, Plasma cholesterol at euthanasia of bone marrow-transplanted hosts. n=6 for both genotypes. C, Antibody titres of bone marrow-transplanted hosts. n=5 to 11 for both genotypes. D, Plasma autoantibody titres in bone marrow-transplanted hosts. n=5 to 10 for both genotypes. E, Oil Red O-stained aortic root sections from female mice for the indicated genotypes. Quantification is shown in the right. Significance determined by 2-way ANOVA. Percentage difference between the 2 genotypes was calculated by area under the curve measurements. All univariate scatter plots are ±SEM. Significance determined by Student t test unless otherwise stated. *P<0.05, ***P<0.001 compared with control mice. AUC indicates area under the curve; GC, germinal center; LDL, low-density lipoprotein; and MDA, malondialdehyde.
Here, we also observed an expansion of hematopoietic and B-cell progenitors in mice maintained on a Western diet. This expansion proceeds after GCs have been formed. Thus, both germline and acute loss of APOE can perturb immune homeostasis, and this effect can be exacerbated by maintaining mice on a Western diet.
Loss of mature B-cells and also GC B-cells reduced but did not entirely abolish the production of autoimmune antibodies. Nevertheless, the removal of these B-cell subsets was sufficient to significantly reduce atherosclerosis burden. This shows that the adaptive immune response that occurs in response to acute hyperlipidemia on APOE loss promotes atherosclerosis, at least with regard to humoral immunity. This does not exclude the possibility that atherosclerosis-dampening responses also occur as we found that the Treg cell population is concomitantly expanded. Regardless, the classical autoimmune features we observe in this inducible Apoe knockout strain, such as GC formation and autoantibody production, underline that atherogenesis and dyslipidemia are intimately linked to the immune system. Recent reports have demonstrated autoimmunity because of cholesterol loading of immune cells in the Apoe −/− liver X receptor β −/− and Abca1 −/− Abcg1 −/− strains. 13, 15 This study adds to the weight of evidence that the use of cholesterol-lowering drugs as anti-inflammatory agents in autoimmune disorders, especially rheumatoid diseases, could have beneficial clinical outcomes.
